| Literature DB >> 22454745 |
Ebrahim M Nashtaei1, Masoud Soheilian, Carl P Herbort, Mehdi Yaseri.
Abstract
PURPOSE: To compare the patterns of uveitis, emphasizing similarities and discrepancies, in the Middle East and Europe.Entities:
Keywords: Europe; Middle East; Patterns of Uveitis; Uveitis
Year: 2011 PMID: 22454745 PMCID: PMC3306117
Source DB: PubMed Journal: J Ophthalmic Vis Res ISSN: 2008-322X
Characteristics of uveitis patients in the Middle East and Europe
| Middle East | |||||||
|---|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey | Saudi Arabia | Saudi Arabia | Israel | Total | |
| Number | 544 | 300 | 761 | 488 | 200 | 400 | 2693 |
| Mean age (SD) | 32.3 (15.2) | 35.7 (−) | 35.4 (15.3) | 38 (−) | 35 (16) | - | 35.2 |
| Age range | - | 5 – 78 | 3 – 83 | 3 – 99 | 7 – 91 | 6 – 75 | 3 – 99 |
| Sex, M/F (M%) | 238/306 (44) | 162/138 (54) | 388/373 (51) | 264/224 (54) | 120/80 (60) | 216/184 (54) | 1388/1305 (52) |
Anatomical types of uveitis in the Middle East and Europe
| Middle East | |||||||
|---|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey | Saudi Arabia | Saudi Arabia | Israel | Total | |
| Anterior | 209 (38.4) | 131 (43.5) | 400 (52.5) | 293 (60) | 119 (59.5) | 183 (45.8) | 1335 (49.6) |
| Panuveitis | 138 (25.4) | 62 (20.5) | 214 (28.1) | 117 (24) | 41 (20.5) | 98 (24.5) | 670 (24.9) |
| Posterior | 101 (18.6) | 80 (26.6) | 97 (12.7) | 54 (11) | 27 (13.5) | 58 (14.5) | 417 (15.5) |
| Intermediate | 96 (17.6) | 27 (9) | 51 (6.7) | 29 (6) | 13 (6.5) | 61 (15.2) | 277 (10.3) |
General causes of uveitis in the Middle East and Europe
| Middle east | ||||||
|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey | Saudi Arabia | Israel | Total | |
| Idiopathic | 226 (41.5) | 102 (34) | 329 (43.2) | 86 (43) | 158 (39.5) | 1121 (41.6) |
| Behcet’s Disease | 47 (8.6) | 78 (26) | 245 (32.2) | 13 (6.5) | 61 (15.3) | 474 (17.6) |
| Toxoplasmosis | 55 (10.1) | 22 (7.3) | 36 (4.7) | 13 (6.5) | 15 (3.8) | 169 (6.3) |
| Herpes | 8 (1.5) | 9 (3) | 22 (2.9) | 32 (16) | 20 (5) | 149 (5.5) |
| FHIC | 36 (6.6) | 8 (2.7) | 39 (5.1) | 7 (3.5) | 6 (1.5) | 115 (4.3) |
| VKH | 21 (3.9) | 3 (1) | 9 (1.2) | 5 (2.5) | 3 (0.8) | 78 (2.9) |
| TB | 8 (1.5) | 4 (1.3) | 3 (0.4) | 21 (10.5) | 3 (0.8) | 76 (2.8) |
| HLA-B27 | 3 (0.6) | 5 (1.7) | 19 (2.5) | 3 (1.5) | 12 (3) | 42 (1.9) |
| SO | 7 (1.3) | 2 (0.7) | 1 (0.1) | 2 (1) | 15 (3.8) | 27 (1.2) |
FHIC, Fuchs Heterochromic Iridocyclitis; VKH, Vogt-Koyanagi-Harada syndrome; TB, Tuberculosis; SO, Sympathic Ophthalmia
Etiology of anterior uveitis in the Middle East and Europe
| Middle East | |||||||
|---|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey | Saudi Arabia | Saudi Arabia | Israel | Total | |
| Idiopathic | 109 (52.2) | 51 (38.9) | 199 (49.8) | 155 (52.9) | 58 (48.7) | 94 (51.4) | 666 (49.9) |
| Behcet’s Disease | 0 (0) | 17 (13) | 125 (31.3) | - | 0 (0) | 1 (0.5) | 143 (13.7) |
| FHIC | 36 (17.2) | 8 (6.1) | 39 (9.8) | 19 (6.5) | 7 (5.9) | 6 (3.3) | 115 (8.6) |
| Herpes | 8 (3.8) | 9 (6.9) | 22 (5.5) | 58 (19.8) | 30 (25.2) | 15 (8.2) | 142 (10.6) |
| TB | 6 (2.9) | 2 (1.5) | 0 (0) | - | 9 (7.6) | 3 (1.6) | 20 (1.9) |
FHIC, Fuchs Heterochromic Iridocyclitis; TB, Tuberculosis
Etiology of posterior uveitis in the Middle East and Europe
| Middle East | |||||||
|---|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey Saudi Arabia | Saudi Arabia | Israel | Total | ||
| Toxoplasmosis | 55 (54.5) | 22 (27.5) | 15 (15.5) | 28 (51.9) | 12 (44.4) | 8 (13.8) | 140 (33.6) |
| Behcet’s Disease | 0 (0) | 21 (26.3) | 40 (41.2) | - | 0 (0) | 2 (3.4) | 63 (17.4) |
| Idiopathic | 3 (3) | 14 (17.5) | 25 (25.8) | - | 0 (0) | 16 (27.6) | 58 (16) |
| Toxocariasis | 11 (10.9) | 1 (1.3) | 0 (0) | - | 0 (0) | 2 (3.4) | 14 (3.9) |
| ARN | 9 (8.9) | 1 (1.3) | 0 (0) | - | 0 (0) | 3 (5.2) | 13 (3.6) |
| Eales | 12 (11.9) | 4 (5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 16 (4.4) |
| TB | 1 (1) | 0 (0) | 1 (1) | - | 8 (29.6) | 0 (0) | 10 (2.8) |
| SO | 0 (0) | 0 (0) | 0 (0) | - | 1 (3.7) | 6 (10.3) | 7 (1.9) |
| VKH | 0 (0) | 0 (0) | 6 (6.2) | - | 0 (0) | 0 (0) | 6 (1.7) |
ARN, Acute Retinal Necrosis; TB, Tuberculosis; SO, Sympathic Ophthalmia; VKH, Vogt-Koyanagi-Harada syndrome
Etiology of panuveitis in the Middle East and Europe
| Middle east | |||||||
|---|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey | Saudi Arabia | Saudi Arabia | Israel | Total | |
| Behcet’s Disease | 47 (34.1) | 37 (59.7) | 115 (53.8) | 30 (25.6) | 13 (31.7) | 58 (59.2) | 300 (44.8) |
| Idiopathic | 31 (22.5) | 15 (24.2) | 60 (28.1) | - | 13 (31.7) | 4 (4.1) | 123 (22.2) |
| VHK | 21 (15.2) | 3 (4.8) | 4 (1.9) | 37 (31.6) | 5 (12.2) | 3 (3.1) | 73 (10.9) |
| MCP | 14 (10.1) | 0 (0) | 7 (3.3) | - | 0 (0) | 0 (0) | 21 (3.8) |
| SO | 7 (5.1) | 2 (3.2) | 1 (0.5) | - | 1 (2.4) | 9 (9.2) | 20 (3.6) |
| Toxoplasmosis | 0 (0) | 0 (0) | 12 (5.9) | - | 1 (2.4) | 7 (7.1) | 20 (3.6) |
| Sarcoidosis | 7 (5.1) | 3 (4.8) | 2 (0.9) | - | 6 (14.6) | 1 (1) | 19 (3.4) |
VKH, Vogt-Koyanagi-Harada syndrome; MCP, Multifocal Choroiditis Panuveitis; SO, Sympathic Ophthalmia
Etiology of intermediate uveitis in the Middle East and Europe
| Middle East | |||||||
|---|---|---|---|---|---|---|---|
| Iran | Turkey (Ankara) | Turkey | Saudi Arabia | Saudi Arabia | Israel | Total | |
| Idiopathic | 83 (86.5) | 22 (81.5) | 47 (92.4) | - | 9 (69.2) | 44 (72.1) | 205 (82.7) |
| Sarcoidosis | 7 (7.3) | 0 (0) | 3 (5.0) | - | 0 (0) | 0 (0) | 10 (4) |
| MS | 4 (4.2) | 0 (0) | 0 (0) | - | 1 (7.7) | 0 (0) | 5 (2) |
| TB | 0 (0) | 0 (0) | 2 (2.5) | - | 2 (15.4) | 0 (0) | 4 (1.6) |
| Behcet’s Disease | 0 (0) | 3 (11.1) | 0 (0) | - | 0 (0) | 0 (0) | 3 (1.2) |
MS, Multiple Sclerosis; TB, Tuberculosis